GENE ONLINE|News &
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
Several start-up companies have been actively engaged in this flourishing field of drug research and development in recent years. They have successively gained the breakthrough therapy designation from the FDA or carried out IPOs. The following are four notable biotechnology companies around the world: Compass Pathways, Atai Life Sciences, MindMed, and Cybin.
It's free! Log in now to read
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
